PharmChem, Inc. (PCHM)
OTCMKTS
· Delayed Price · Currency is USD
3.000
0.00 (0.00%)
At close: Apr 25, 2025
10.70% (1Y)
| Market Cap | 13.94M |
| Revenue (ttm) | 25.73M |
| Net Income (ttm) | -2.04M |
| Shares Out | 4.65M |
| EPS (ttm) | -0.35 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.25 (8.42%) |
| Ex-Dividend Date | Oct 10, 2024 |
| Volume | 2,650 |
| Average Volume | 9,465 |
| Open | 3.000 |
| Previous Close | 3.000 |
| Day's Range | 3.000 - 3.000 |
| 52-Week Range | 2.510 - 4.000 |
| Beta | 0.69 |
| RSI | 43.24 |
| Earnings Date | n/a |
About PharmChem
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas. [Read more]
Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 170
Stock Exchange OTCMKTS
Ticker Symbol PCHM
Financial Performance
Financial StatementsNews
PharmChem, Inc. Announces Exploration of Strategic Alternatives
FORT WORTH, Texas , Feb. 3, 2025 /PRNewswire/ -- PharmChem, Inc.("PharmChem" or the "Company") (OTC: PCHM) the leading provider of sweat patches to detect drugs of abuse, today announced that the Comp...
2 months ago - PRNewsWire
PharmChem, Inc. Announces Tender Offer
FORT WORTH, Texas--(BUSINESS WIRE)--PharmChem, Inc. (“PharmChem” or the “Company”) (OTC: PCHM) today announced that the PharmChem Board of Directors has approved the repurchase of up to $5 million agg...
3 years ago - Business Wire